Literature DB >> 25265366

Vaginal suppositories containing Lactobacillus acidophilus: development and characterization.

Francisca Rodrigues1, Maria João Maia, José das Neves, Bruno Sarmento, Maria Helena Amaral, Maria Beatriz P P Oliveira.   

Abstract

OBJECTIVE: The aim of this study was to develop and characterize suppositories for vaginal delivery of Lactobacillus acidophilus.
METHODS: Formulations were performed in order to select suitable excipients based on suppository formation feasibility and cytotoxicity. Solid body and hollow-type suppositories were prepared by melting and molding using poly(ethylene glycol) (PEG) 400 and 4000 or Witepsol (WIT) H12 as excipients. L. acidophilus was incorporated in the molten mass before molding solid body suppositories or added as suspension into the cavity of hollow-type suppositories and sealed molten excipients. Cytotoxicity of the selected excipients was evaluated by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium and lactate dehydrogenase assays against VK2/E6E7, HEC-1-A and HeLa cells. Suppositories were characterized regarding organoleptic characteristics, mass uniformity, disintegration, breaking strength and L. acidophilus in vitro release.
RESULTS: PEG 400, PEG 4000 and WIT H12 showed the absence of toxicity when tested using three different vaginal cell lines. Obtained vaginal suppositories presented uniform and mild texture, a content of about 1 × 10(8) colony-forming units, completely disintegrated in simulated vaginal environment in less than 60 min and provided sustained in vitro release of L. acidophilus. Release studies further demonstrated that incorporation of freeze-dried bacteria did not result in significant loss of viable bacteria, thus supporting that vaginal suppositories may possess good properties to promote the replacement of the vaginal flora in situations of urinary tract infection.
CONCLUSION: Hollow-type suppositories showed to be promising delivery vehicles for vaginal delivery of probiotics.

Entities:  

Keywords:  Cytotoxicity; HEC-1A cells; HeLa cells; LDH; MTS; VK2/E6E7 cells; in vitro release; probiotics; vaginal drug delivery

Mesh:

Substances:

Year:  2015        PMID: 25265366     DOI: 10.3109/03639045.2014.963864

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  2 in total

Review 1.  Characteristics of Probiotic Preparations and Their Applications.

Authors:  Guangqiang Wang; Yunhui Chen; Yongjun Xia; Xin Song; Lianzhong Ai
Journal:  Foods       Date:  2022-08-16

2.  Evaluation of the Live Biotherapeutic Product, Asymptomatic Bacteriuria Escherichia coli 2-12, in Healthy Dogs and Dogs with Clinical Recurrent UTI.

Authors:  G Segev; J E Sykes; D J Klumpp; A J Schaeffer; E M Antaki; B A Byrne; R E Yaggie; J L Westropp
Journal:  J Vet Intern Med       Date:  2017-12-15       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.